I nbred strains of mice have been used as experimental model systems for the past 100 years (1) , and the critical role that murine models play in elucidating the underlying mechanisms that regulate normal and disease states cannot be overestimated, as evidenced by their use over a wide array of medical research fields (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Scientists rely on both the genotypic and phenotypic stability of inbred strains to carry out studies that will, overall, generate consistent and reproducible results and define mechanistic pathways. However, the very design and maintenance of the genetic fidelity of inbred mouse strains is contrary to the fundamentals of the evolutionary process. Therefore, despite cautious breeding protocols, over time it is likely that some amount of genetic drift will occur within these strains. Whether such genetic drift will adversely affect our ability to define mechanistic processes may only be determined by empirical comparison of early and later results from similarly designed experiments.
Experimental mouse models using MHC-mismatched and MHC-matched, minor histocompatibility Ag (miHA) 3 -mismatched strain combinations have been the foundation for elucidating many of the mechanisms that underlie the complications of allogeneic blood and marrow transplantation (BMT) (14) , which has been successfully used in the clinic as a curative therapy for the treatment of hematological malignancies, and more recently some solid tumors (15) (16) (17) . It was the preclinical studies that clearly established that donor T cells present in the marrow inoculum were primarily responsible for the complication of graft-vshost disease (GVHD) (18 -21) . Complete removal of donor T cells was shown to minimize the development of GVHD (18, 19) ; however, when this approach was tried clinically, it was often associated with increased incidence of graft failure, opportunistic infection, and leukemic relapse (18, 22, 23) . Evidence in murine models also suggested that donor T cells with overlapping anti-host alloreactivity or with tumor-specific reactivity also had the capability of mediating graft-vs-leukemia (GVL) effects (24 -26) . With eventual recognition of the potential for GVL responses in the clinical BMT setting to eliminate residual tumor cells that had survived cytoreductive therapy, and thus prevent leukemic relapse (27, 28) , allogeneic BMT developed as an immunotherapeutic tool, providing donor T cells at either time of hematopoietic stem cell transplant or at later stages to counter malignant disease (29 -31) .
In the MHC-matched transplant setting, GVHD is caused by alloreactive donor T cells aimed at miHA, which are endogenously or exogenously derived peptides originating from polymorphic self-proteins that can be presented by either MHC class I or II molecules on APC (32) . Several types of polymorphisms can lead to the generation of miHA (33) . Many miHA are created from single nucleotide polymorphisms (SNP) occurring in the coding region of a gene leading to an amino acid substitution that result in Ag disparities between donor and host. These include the murine APC presentation of MHC class I-restricted miHA H3, H7, H13, and H47 peptides (34 -37) . Alternatively, miHA may be created by differential or induced gene expression, such as the case of the H60 and H28 Ags, which are expressed in the BALB.B, but not in the C57BL/6 mouse strain (38 -41) . Additionally, differential Ag processing (42) or posttranslational modifications (43) may lead to miHA expression. There are likely hundreds of miHA that may be expressed between two MHC-matched individuals; however, due to the phenomenon of immunodominance, at least in vitro, the actual immune response that develops may be restricted to a limited set of hierarchical epitopes (44) . However, in vitro immunodominance responses do not carry over into in vivo GVHD responses, where other factors, including tissue-restricted expression of miHA and levels of expression, may be critical for allowing miHA-specific T cells to cause pathological tissue injury in target organs (45) .
In most experimental murine MHC-matched, miHA-mismatched models of allogeneic BMT CD8 ϩ T cells, either dependently or independently of CD4 ϩ T cell helper functions, elicit a severe and lethal acute GVHD response (20, 46) . In some cases, CD4
ϩ T cells alone can mediate a similar level of disease (47) . Historically, in the mid-1980s, the B10.BR3 CBA (H-2 k ) GVHD model was found to be mediated by a CD4-independent, CD8 ϩ T cell response to miHA, and B10.BR CD4 ϩ T cells, by themselves, were limited in their capacity to cause lethal disease in CBA recipients (20) .
In contrast to previous results, in the present study, we observed that both CD4 ϩ and CD8 ϩ donor B10.BR T cells were able to induce lethal acute GVHD in CBA recipients. Additionally, there was an increased mortality in transplanted mice receiving only B10.BR-derived anti-T cell-depleted bone marrow (ATBM) cells. These results suggested that perhaps these B10.BR mice were somehow different from the original strain, and upon contacting the vendor and informing them of these inconsistencies, we were able to obtain the original strain, resurrected from cryopreserved embryos frozen in 1991, designated B10.BR/Jrep. We hypothesized that genetic drift had resulted in 1) the altered expression of either a single or set of miHA in the B10.BR mice leading to the generation of a different substrain (designated B10.BR/Jdrif), and 2) B10.BR/Jdrif T cells could now potentially recognize miHA differences in B10.BR/Jrep, as well as CBA BMT recipients. Here, we show through TCR V␤ CDR3 size spectratype analyses, in vitro immunological assays, and in vivo GVHD studies that one or more miHA disparities between the B10.BR/Jdrif and B10.BR/ Jrep strains have likely arisen, causing enhanced alloreactivity of B10.BR/Jdrif CD4 ϩ T cells. Additionally, these new disparities or other unrelated altered gene expressions have resulted in the inability of ATBM cells from B10.BR/Jdrif mice to effectively reconstitute the immune system in either an allogeneic or syngeneic transplant setting, failing to support long-term survival.
Materials and Methods

Mice
Male B10.BR-H-2 k H2-T18a/SgSnJ (stock no. 000465; B10.BR/Jdrif), B10.BR-H-2 k H2-T18a/SgSnJJrep (stock no. 004804; B10.BR/Jrep), C57BL/6J (B6), and CBA/J (CBA) mice were purchased from The Jackson Laboratory, housed in a sterile environment in microisolator cages, and given autoclaved food and acidified water (pH 2.5) ad libitum. In some experiments, recipient mice were given antibiotic food (Modified LabDiet 5001 with 1.2% sulfamethoxzole, 0.2% trimethoprim; W. F. Fisher and Son) for 10 days before the start of the experiment and/or antibiotic water (100 mg/L neomycin, 10 mg/L polymixin B; Sigma-Aldrich) starting at day Ϫ1 and continuing for 7 days. Donor and recipient mice were used at 8 -12 wk of age. The Hackensack University Medical Center's Institutional Animal Care and Use Committee approved all protocols used in this study.
Flow cytometry
Spleens and lymph nodes (LN) were harvested from B10.BR/Jdrif and B10.BR/Jrep mice. Cell suspensions were pooled from three or more mice, washed in FACS buffer (1ϫ PBS containing 1% BSA and 0.02% sodium azide), and incubated with the appropriate fluorochrome-conjugated mAb diluted 1/100 in FACS buffer. FITC-conjugated mAb included anti-CD4, anti-CD8a, anti-B220 (CD45R), anti-NK1.1, anti-Mac-1 (CD11b), anti-F4/ 80, anti-H-2k k , and anti-I-A k . PE-conjugated mAb used were anti-CD8a, anti-CD3e, anti-Gr-1 (Ly-6G), and anti-CD11c (all purchased from BD Pharmingen). Cells were acquired and analyzed using a FC500 flow cytometer (Beckman Coulter). Staining was performed separately on two to three groups of mice, and statistical significance was determined using Student's t test.
Preparation of cells for in vivo GVHD assays
All in vitro manipulations of cells were performed in 1ϫ PBS (Mediatech) with 0.1% BSA (Sigma-Aldrich). Bone marrow cells were harvested from the femura and tibiae of donor mice. Cells (3 ϫ 10 7 /ml) were incubated with anti-thymocyte mAb (J1j) at a 1/100 dilution along with guinea pig CЈ (1/5 dilution) (Rockland) for 45 min in a 37°C H 2 O bath to obtain ATBM. T cell-enriched donor cell populations were prepared from pooled LN and RBC-depleted spleen cells. B cells were removed by panning on petri dishes precoated with a 5 g/ml solution of goat anti-mouse IgG (Cappel) in 1ϫ PBS for 1 h at 4°C. The remaining T cell-enriched population was depleted of either CD4 ϩ or CD8 ϩ T cells by incubating with anti-CD8 (3.168) or anti-CD4 (RL172) mAb at 1/100 dilution along with CЈ (1/5) for 45 min in a 37°C H 2 O bath.
In vivo GVHD assay
On the day of the experiment, recipient mice were exposed to lethal irradiation with either 8.5 Gy (single dose) or 11 Gy (split dose) using a 137 Ce source (Gammacell 40 Exactor; MDS Nordion). At least 5 h later, mice were injected i.v. with ATBM cells (2 ϫ 10 6 ) alone or in combination with donor T cell populations in quantities denoted for each experiment. Mice were checked daily for morbidity and mortality and were weighed twice weekly. Data were pooled from two to three separate experiments and median survival times (MST) were determined. Statistical significance of survival between experimental groups was determined using the nonparametric Wilcoxon test.
Preparation of RNA and complementary DNA and CDR3 size spectratyping
CD4
ϩ T cells were isolated from the spleen and LN population of donor mice, as described above, and transplanted into irradiated recipients in the absence of ATBM cells. Total cellular RNA, RT-PCR, and CDR3 size spectratype analysis was performed, as previously described (48, 49) . In brief, ϳ10 days after transplantation, spleens and LN were harvested and pooled from five mice and cells were homogenized in Ultraspec reagent (Biotecx Laboratories). Control CD4 ϩ T cell populations were obtained from the spleens and LN of naive B10.BR/Jdrif or B10.BR/Jrep mice. RNA was isolated by chloroform extraction followed by isopropanol precipitation. The poly(A) ϩ portion of the total RNA was converted into cDNA using oligo(dT) as a primer for reverse transcription. Seminested PCR was performed by using a panel of V␤ sense oligoprimers (IDT Technologies) and two C␤ antisense oligoprimers, with the second C␤ being fluorescently labeled (PE Applied Biosystems). PCR products were run on an ABI 3130 capillary gel system at the Molecular Resource Facility of The University of Medicine and Dentistry of New Jersey (Newark, NJ). Analyses were performed using GeneMapper software (version 3.7) from PE Applied Biosystems.
Quantitation of CDR3 size usage
Experiments were repeated three or more times for control and experimental groups with three to five mice in each group. TCR V␤ skewing was defined as an average peak area greater than the average control area plus 10 ϫ SD. Spectratype histograms generated from naive B10.BR/Jrep or B10.BR/Jdrif CD4 ϩ T cells were used as the baseline for the B10.BR/Jrep or B10.BR/Jdrif anti-CBA spectratype analysis. For the B10.BR/Jdrif anti-B10.BR/Jrep spectratype analysis, spectratype histograms generated from naive B10.BR/Jdrif CD4 ϩ T cells were used as the baseline.
ELISPOT assay
Millipore 96-well multiscreen plates with a high-protein binding Immobilon-P membrane (Fisher Scientific) were coated with affinity-purified anti-mouse IFN-␥ mAb (clone AN-18; 10 g/ml) (eBioscience) at 4°C
overnight. Responder cells were prepared by harvesting LN from mice presensitized 3 wk earlier with 1.7 ϫ 10 7 stimulator splenocytes via i.p. injection, and T cell populations were enriched, as described above. Stimulator cells were obtained from spleens and irradiated at 30 Gy. Responders and stimulators were plated at a ratio of 1:2 in complete RPMI 1640 media (Mediatech) containing 10% FBS (HyClone), 2 mM L-glutamine, penicillin (50 IU/ml)/streptomycin (50 g; Mediatech), and 2-ME (10 Ϫ5 M) and incubated for 48 h at 37°C. Subsequently, wells were washed with PBS and PBS-containing 0.01% Tween 20 (Sigma-Aldrich). Biotinylated anti-mouse IFN-␥ detection mAb (clone R4-6A2; 1 g/ml) (eBioscience) was added and incubated for 2 h at room temperature, after which wells were washed as described above. Avidin-HRP (eBioscience) diluted 1/1000 in PBS was added for 1 h at room temperature. Spots were developed by adding substrate solution (3,3Ј-diaminobenzidine tetrahydrochloride (DAB); Sigma-Aldrich) for 10 min, and enumerated using an Immunospot plate reader, software version 3.2 (CTL). Spot counts from three triplicate wells were averaged and data were combined from three separate experiments. Statistical significance was determined using Student's t test.
Histopathology
At days 10 and 25 posttransplantation, GVHD target organs (ear, tongue, spleen, liver, gut) were harvested for histopathology. Organs were placed in Tissue-Tek OCT compound (Sakura Finetek), snap-frozen in liquid nitrogen, and stored at Ϫ80°C. Sections (6 m thick) were created from frozen tissue using a Leica CM 1850 cryostat (Leica Microsystems). Histological staining was performed using H&E dyes (Sigma-Aldrich).
Microarray analysis
Bone marrow was harvested from femura and tibiae of B10.BR/Jdrif or B10.BR/Jrep mice and depleted of cells expressing lineage markers. Briefly, cell suspensions were stained with a biotin mouse lineage panel (CD3e, CD11b, CD45R, Gr-1, TER-119; BD Pharmingen) followed by anti-biotin microbeads (Miltenyi Biotec). The labeled cell suspensions were passed twice through the autoMACS cell separation system (Miltenyi Biotec) and the negative fraction after the second pass-through was collected as the lineage-negative (Lin Ϫ ) population. The streptavidin-PEstained negative fraction was determined to be Ͻ4% lineage positive by flow cytometry. Frozen cell pellets were sent to SABiosciences for RNA isolation and microarray services. Gene expression analysis was performed using the Oligo GEArray Mouse Hematopoietic Stem Cells and Hematopoiesis Microarray (OMM-054). The data discussed in this publication have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) and are accessible through GEO series accession no. GSE17471 (www.ncbi.nlm.nih.gov/geo).
Results
Hematopoietic cell distribution in B10.BR/Jdrif vs B10.BR/Jrep mice
Gross pathological examination of normal B10.BR/Jdrif mice at 8 -12 wk of age revealed the appearance of abnormally enlarged spleens in ϳ50% of these animals. In correlation with this observation, more cells on average were recovered from the spleens of B10.BR/Jdrif mice as compared with B10.BR/Jrep mice (Table I; 91.67 ϫ 10 6 and 71.08 ϫ 10 6 cells/spleen, respectively; p Ͻ 0.01). Additionally, an increase in the presence of larger sized cells was observed via light microscopy and forward scatter in flow cytometric analysis. Therefore, the distribution of various cell types in the spleen and LN populations of the two B10.BR substrains was more extensively examined by flow cytometric analyses, evaluating the percentage and absolute numbers of CD3 ϩ , CD4 ϩ , and
, and MHC class I (H-2 k ) and class II (I-A k ) expressing cells. The combined results from three independent experiments indicated that the most prominent differences were observed in the Mac-1 ϩ myeloid cell population (Table I and Fig. 1 ). B10.BR/Jdrif mice displayed a significant increase ( p Ͻ 0.01) in the percentage of Mac-1 ϩ cells in the spleen (Fig. 1A , right panels; B10.BR/Jrep, 13.0%; B10.BR/Jdrif, 42.1%). To differentiate between macrophages and granulocytes, cells were also stained with mAb to the macrophage-specific ϩ and CD8 ϩ T cell subsets, but no significant differences were detected (data not shown).
Increased anti-CBA GVHD potential of CD4 ϩ T cells from B10.BR/Jdrif mice compared with B10.BR/Jrep mice in vivo
Historically, GVHD in the B10.BR3 CBA (H-2 k ) model was found to be predominantly a CD4-independent, CD8 ϩ T cell-mediated response directed to host miHA (20) . Moreover, CD4
ϩ T cells alone were mostly ineffective at mediating acute lethal GVHD, although some did succumb to disease at much later time points than did their donor CD8 counterparts (20) . To test the possibility that the observed altered CD4 ϩ /CD8 ϩ T cell ratio, along with an increase in granulocytes displayed in the B10.BR/ Jdrif splenic population, might affect the GVHD potential of either T cell subset in this transplantation model, CBA mice were lethally irradiated (8.5 Gy) and transplanted with ATBM cells (2 ϫ 10 6 ) alone, or with unseparated (1 ϫ 10 7 ), CD8 ϩ (5 ϫ 10 6 ), or CD4 ϩ FIGURE 1. B10.BR/Jdrif mice display an altered CD4 ϩ /CD8 ϩ T cell ratio, as well as increased granulocytes as compared with B10.BR/Jrep mice. A, Spleens and lymph nodes were harvested from either B10.BR/Jdrif or B10.BR/Jrep mice. Cell suspensions were stained with anti-CD4 FITC, anti-CD8 FITC, anti-CD3 PE (lymph nodes), or Mac-1 FITC (spleens). Cells were gated using a lymphocyte gate (lymph nodes) or a live gate (spleens). The percentage of double-positive events (lymph nodes) or FITC-positive events (spleen) is shown. One representative experiment of three is shown. B, Spleens and bone marrow were harvested from B10.BR/Jdrif or B10.BR/Jrep mice. Cell suspensions were stained for granulocytes using anti-Gr-1 PE and macrophages using anti-F4/80 FITC. Both spleens and bone marrow were gated on live events (top panels). One representative experiment of two is shown. Granulocytes are positive for only Gr-1, while macrophages express both Gr-1 and F4/80. The percentage of positive events is shown in each quadrant.
(5 ϫ 10 6 ) T cells from either B10.BR/Jdrif or B10.BR/Jrep mice. As expected, CBA recipient mice of CD8 ϩ and unseparated T cells from B10.BR/Jdrif (87% and 100% mortality, respectively; Fig.  2A ) and B10.BR/Jrep (47% and 100% mortality, respectively; Fig.  2C ) mice developed the typical clinical signs of GVHD, including ruffled fur, diarrhea, and weight loss, before succumbing to disease. Of utmost importance, B10.BR/Jdrif CD4 ϩ T cells also caused lethal GVHD in recipient mice, with 100% mortality (Fig.  2B) , whereas B10.BR/Jrep CD4 ϩ T cells resulted in long-term survival (Fig. 2D) , with only slight weight loss (Ͻ3%; data not shown), but with no other clinical symptoms of GVHD. Mice were sacrificed at days 10 or 25 posttransplantation, GVHD target organs were harvested, and frozen tissues were sectioned and H&E stained to determine histopathology. Tissue injury typical of GVHD was observed in the tongue (marked by mononuclear cell infiltration, basal cell layer vacuolization, and an increase in dyskeratotic cells; 
TCR V␤ spectratype analysis of B10.BR/Jdrif vs B10.BR/Jrep anti-CBA GVHD responses
The observed discrepancy in the GVHD-inducing potential of CD4 ϩ T cells from B10.BR/Jdrif and B10.BR/Jrep mice suggested that the cells may be responding to different miHA in the CBA recipients. Therefore, TCR V␤ spectratype analysis was performed to identify any differential T cell responses, as reflected by nonoverlapping CDR3 size skewing between the V␤ repertoires of the responding B10.BR/Jdrif and B10.BR/Jrep anti-CBA alloreactive CD4 ϩ T cells. To this end, CBA mice were exposed to lethal irradiation (11 Gy, split dose) and transplanted with CD4 ϩ T cells (5 ϫ 10 6 ) from either B10.BR/Jdrif or B10.BR/Jrep donors, in the absence of ATBM cells (to allow more focus on the responding populations), and spleens were harvested 10 days posttransplantation for spectratype analysis. The V␤ family skewing results are summarized in Table II , and representative spectratype histograms are shown in Fig. 3A . V␤ families marked with a plus sign denote a skewed distribution of CDR3 size lengths in one or more bands, which indicates clonal or oligoclonal alloreactive T cell expansion within that V␤ family. A differential skewing pattern was observed in 10 of the 20 V␤ families between the B10.BR/Jdrif and the B10.BR/Jrep CD4 ϩ anti-CBA repertoires (Table II) 
B10.BR/Jdrif anti-B10.BR/Jrep TCR V␤ spectratype analysis
Based on the observed differential B10.BR/Jdrif and B10.BR/Jrep anti-CBA CD4 ϩ T cell responses, we next considered whether there could also be alterations in the expression of miHA between the two B10.BR substrains. Spectratype analysis was thus used to evaluate biased TCR CDR3 size usage in the V␤ families of B10.BR/Jdrif donor CD4 ϩ T cells responding to miHA expressed in B10.BR/Jrep recipients. B10.BR/Jrep mice were exposed to lethal irradiation (11 Gy, split dose), injected i.v. with 2 ϫ 10 7 B10.BR/Jdrif CD4 ϩ T cells, and, 10 days later, splenocytes were harvested and processed for V␤ spectratype analysis. T cells from naive B10.BR/Jdrif mice were used as a baseline control for CDR3 length distribution. The observed V␤ family skewings are summarized in Table III, Spleens were harvested at day 10 after transplant, RNA was extracted, and V␤ spectratype analysis was performed. Skewing is defined as a peak area greater than the mean of the control (naive B10.BR/Jdrif or B10.BR/Jrep mice) plus 10 ϫ SD and is indicated by a plus sign.
B10.BR/Jdrif ATBM fails to reconstitute the hematopoietic system following allogeneic or syngeneic transplantation
In an effort to demonstrate that the alloreactive responses to miHA observed in the spectratype analysis and in the in vitro IFN-␥ ELISPOT assay were physiologically relevant to GVHD, B10.BR/ Jdrif CD4 ϩ T cells were transferred into lethally irradiated B10.BR/Jrep recipients. B10.BR/Jrep hosts were injected i.v. with ATBM cells (2 ϫ 10 6 ) alone or along with either unseparated T cells (1.5 ϫ 10 7 ) or CD4 ϩ T cells (2 ϫ 10 7 ) from host-presensitized B10.BR/Jdrif donors (3 wk prior, 2 ϫ 10 7 B10.BR/Jrep splenocytes were injected i.p.). At ϳ20 days post-BMT, recipient mice from all transplantation groups began to rapidly lose weight in the absence of any other symptoms, andy the began to die. Most surprisingly, all mice receiving ATBM cells alone were dead by day 40 (MST of 34 days) (Fig. 5A) . Interestingly, in recipients receiving ATBM cells plus unseparated T cells, the MST was extended to 74 days, and even more significantly in the CD4 ϩ T group, to 97 days ( p Յ 0.01), although most recipients still died in each group. The transplantation of ATBM cells into either allogeneic or syngeneic lethally irradiated recipients typically results in long-term survival with the reconstitution of all lineages in the hematopoietic compartment. The unanticipated mortality observed in the B10.BR/Jrep recipients of B10.BR/Jdrif ATBM cells might possibly have been the result of host rejection of the transplanted bone marrow cells or, alternatively, a hematopoietic deficiency of the transplanted bone marrow cells. In an effort to distinguish these possibilities, a syngeneic transplantation model using B10.BR/ Jdrif donors and recipients was utilized. Recipient mice were exposed to lethal irradiation (11 Gy, split dose) and injected with ATBM cells alone or along with unseparated T cells (1.5 ϫ 10 7 ) or CD4 ϩ T cells (2 ϫ 10 7 ) from syngeneic donors. The results indicated that mice receiving ATBM cells alone exhibited 80% mortality with a MST of 40 days (Fig. 5B) . In these studies, mice receiving ATBM cells plus unseparated T or CD4 ϩ T cells exhibited somewhat better survival. These results suggested that, in addition to the altered recognition of miHA, the bone marrow cells from B10.BR/Jdrif mice displayed an inability to support longterm survival.
In an effort to determine that the bone marrow niches in the recipient mice were still capable of supporting hematopoietic reconstitution, lethally irradiated B10.BR/Jrep or B10.BR/Jdrif recipients were injected with ATBM cells (2 ϫ (Fig. 5C) .
The possibility that the bone marrow cells from B10.BR/Jdrif mice were unable to engraft in recipient mice was examined by fluorescent mAb staining of the Ly9.1 surface Ag, which is expressed only by CBA lymphocytes. Splenocytes from CBA recipient mice transplanted with B10.BR/Jdrif ATBM cells were examined by flow cytometry on day 38 posttransplantation. In nonirradiated, normal CBA mice 95.86% of lymphocytes stained positive for the surface Ag Ly9.1, whereas only 0.46% of lymphocytes are positive in the B10.BR/Jdrif mice. The presence of only 9.7% Ly9.1 ϩ lymphocytes in the CBA recipients of B10.BR/ Jdrif ATBM indicated 90% B10.BR/Jdrif donor chimerism.
To further characterize the diminished survival capacity, we examined the splenic hematopoietic compartment at day 25 post-BMT via flow cytometry. Both lethally irradiated B10.BR/Jdrif and B10.BR/Jrep recipients of B10.BR/Jdrif ATBM cells exhibited a drastically reduced B220
ϩ B cell population (39% and 38%, respectively) and an increase in T cells (50% CD3 ϩ ) in the lymphocyte compartment, as compared with lethally irradiated B10.BR/Jdrif mice receiving B10.BR/Jrep ATBM cells (81% B220 ϩ , 10% CD3 ϩ ) (Table IV) . Additionally, the percentage of Mac-1 ϩ cells was increased (50% and 58% vs 25%) and MHC class II (I-A k ) expressing cells were reduced (25% and 22% vs 69%) in recipients of B10.BR/Jdrif ATBM. Mice receiving either CD4 ϩ or unseparated T cells along with B10.BR/Jdrif ATBM cells exhibited similar lymphocytic reconstitution to those receiving T cells, respectively. Spleens were harvested at day 10 posttransplant, RNA was extracted, and V␤ spectratype analysis was performed. Skewing is defined as a peak area greater than the mean of the control (naive B10.BR/Jdrif mice) plus 10 ϫ SD and is indicated by a plus sign.
ATBM alone at day 25 post-BMT. These results supported the conclusion that bone marrow cells from B10.BR/Jdrif mice reconstituting the hematopoietic compartment in a BMT setting displayed key abnormalities in the numbers within the B cell, T cell, and macrophage compartments.
Gene expression profiling of lineage-negative (Lin Ϫ ) bone marrow cells from B10.BR/Jdrif and B10.BR/Jrep mice
In the absence of BMT, lethally irradiated mice succumb to hematopoietic failure within the first 2 wk following irradiation. The unexpected mortality observed at the later time points (20 -45 days) after transplantation of B10.BR/Jdrif ATBM cells suggested that some mature hematopoietically derived cells in the donor inoculum could initially maintain engraftment, but there might be a long-term deficiency in hematopoiesis. Hypothetically, any defects in hematopoietic potential might be reflected by gene expression differences in early progenitor Lin Ϫ cells. To test this possibility, gene profiling analysis was used to compare the expression of genes involved in hematopoiesis from Lin Ϫ cells of the bone marrow between B10.BR/Jdrif and B10.BR/Jrep mice. The results indicated several genes with differential expression (Ͼ1.5-fold difference after normalization) between the two substrains. There were two underexpressed genes in B10.BR/Jdrif vs B10.BR/Jrep mice, Crip2 and Gab3. On the other hand, 25 genes were overexpressed in B10.BR/Jdrif vs B10.BR/Jrep mice ( Fig. 6 and Table  V) . Of note, several of these genes, including Ctnnb1, Cbfb, Cdc42, Flt3, Hmgb3, Irf8, Kit, and Vav1, have previously reported associations with hematopoietic engraftment and differentiation. These results indicated that the transcriptional profile was altered between the B10.BR/Jdrif and B10.BR/Jrep Lin Ϫ bone marrow populations, potentially providing some insight as to the observed altered engraftment potential of the B10.BR/Jdrif ATBM cells.
Discussion
Genetic drift is an evolutionary process that results in a change in allele frequencies from one generation to another due to random probability. Over time, mutations accumulate and become fixed in the population. It is highly dependent on population size: the smaller the population, the greater tendency to drift. In a small population, sampling errors are more likely to result in a greater change in allele frequency from one generation to the next, leading to an allele frequency that varies considerably from former generations. In terms of inbred mouse strains, genetic drift can be caused by a number of factors, including residual heterozygosity in a breeding colony, spontaneous mutations that go undetected and become fixed in a colony, and separation of a subcolony from its parent colony for more than 20 generations (1). Although regulatory mechanisms are in place to minimize genetic drift, such as rederiving strains from frozen embryo stocks every five generations, genetic drift may still go undetected and persist in any given Most recently, Watkins-Chow and Pavan, using a SNP genotyping panel of a portion of the genome, assessed genetic copy number and expression variation within the C57BL/6J inbred mouse strain. Among F 1 progeny, they discovered two genes on chromosome 19 with copy number variations and suggested that these differences can influence interpretation of physiological, biomedical, and behavioral experiments (55) . These examples underscore the fact that genetic drift is a common occurrence in inbred strain populations, and while strains from breeding colonies in different institutions are assumed to be genetically identical, it is clear that this may not always be the case.
In the present study, we report that the genetic drift in the B10.BR strain has led to altered hematopoietic cell distribution, altered expression/recognition of a single or possibly multiple miHA, and the inability to maintain long-term survival after BMT. While using the MHC-matched, miHA-mismatched B10.BR3 CBA murine model of BMT in our laboratory, it was determined that both B10.BR CD4 ϩ and CD8
ϩ T cells were able to induce lethal GVHD, whereas only CD8 ϩ T cells had been previously reported to mediate the disease (20) . This observation suggested that expression of B10.BR class IIrestricted miHA, originally shared with CBA and recognized as self, had been altered in the B10.BR mice, leading to a new miHA disparity between these strains of mice. The original strain (denoted B10.BR/Jrep), resurrected from frozen embryos, reiterated the original observations and confirmed that CD4 ϩ T cells were unable to mediate severe lethal GVHD in CBA recipients.
Further support for the alteration of expression of miHA between the B10.BR/Jdrif and the B10.BR/Jrep mice was demonstrated by the TCR V␤ spectratype analysis, in which different V␤ T cell families from the two strains exhibited alloreactive expansions directed against miHA expressed in CBA recipients (Table II) MiHA recognition is a complex process. It involves elements related to Ag generation (gene expression in appropriate tissue, epitope processing, and presentation), as well as those related to T cell responses (TCR affinity and avidity, and ensuing intracellular signal transduction). Genetic differences between two populations do not necessarily translate into miHA disparities. As such, it is not surprising that all miHA reported until now have been described between established, divergent mouse strains or in the context of the female anti-male immune response (Ref. 33 and citations within). Our findings demonstrate that miHA can, in fact, arise due to genetic drift occurring within a stably bred mouse strain.
The functional immune alloresponsiveness of the B10.BR/Jdrif CD4 ϩ T cells was demonstrated in the IFN-␥ ELISPOT assays performed using both B10.BR/Jrep and CBA stimulator cell populations. The comparable IFN-␥ producing cell frequency responses to both sets of stimulators (ϳ1:18,000 cells) were to be expected between MHC-matched strains. The minimum number of miHA disparities required to elicit lethal GVHD varies between different strain combinations. For example, in the C57BL/ 63 BALB.B model, the single CD8 ϩ V␤14 ϩ T cell family can cause severe and lethal disease, presumably representing a limited set of miHA (56) . At the same time, other studies have demonstrated that single miHA alone may be insufficient for the induction of GVHD in vivo (57, 58) . For example, the B6 dom1 miHA is a target for the induction of GVHD when coexpressed with other miHA, but when transplants were performed with T cells that only differed by B6 dom1 , GVHD was not induced (25) . Equally important is the tissue-specific expression of the miHA, as in the case of the single CD4 ϩ V␤11 ϩ T cell family capacity to infiltrate the gut and cause lethal GVHD in the B63 BALB.B model, while the infiltration of multiple other V␤ families into other GVHD target tissues did not result in lethal disease (48, 59) . The breadth of the CDR3 size skewing in the B10.BR/Jdrif CD4 ϩ T cell anti-CBA repertoire as compared with the anti-B10.BR/Jrep repertoire may also be a reflection of the extent of miHA disparity. Greater miHA disparity in the B10.BR/Jdrif anti-CBA vs B10.BR/Jdrif anti-B10.BR/Jrep response is also supported by the in vivo GVHD studies, whereby severe lethal GVHD was observed after transplantation of B10.BR/Jdrif CD4 ϩ T cells into only CBA recipients.
The observation that B10.BR/Jdrif mice displayed splenomegaly with an increased percentage of CD8 ϩ T cells in both the spleen and LN, as well as increased percentages of granulocytes and NK cells in the spleen (Table I) , initially suggested that the mice were suffering from an opportunistic infection. Treating both the donor and recipient mice with antibiotic food and water before and after transplantation slightly extended the life span of recipient mice, but a high incidence of transplant-related mortality (Ͼ80%; data not shown) was still observed. Donor and recipient mice also tested negative for a wide range of common murine bacterial and fungal infections. While the possibility of a viral pathogen has not been eliminated, this is unlikely due to the fact that B10.BR/Jdrif mice were housed with the B10.BR/Jrep mice in an open-air environment by the supplier, and that irradiated B10.BR/Jdrif recipients of B10.BR/Jrep ATBM cells all survived. Additionally, if there is an infectious agent involved in the high mortality observed in the B10.BR/Jdrif or B10.BR/Jrep recipients of B10.BR/Jdrif ATBM cells (Fig. 5) , it would seem to be transferred only with the ATBM cells.
Flow cytometric analysis at day 25 post-BMT revealed a significant increase in the percentage of both CD4 ϩ and CD8 ϩ T cells and a corresponding decrease in the B cell compartment (B220 ϩ ) in the spleens of mice receiving B10.BR/Jdrif ATBM cells, as compared with those transplanted with B10.BR/Jrep ATBM cells (Table IV) . It is not yet clear whether the T cell expansions are polyclonal or oligoclonal in nature; the latter would suggest an ongoing response to an infectious agent. Additionally, there was a 2-fold increase in Mac-1 ϩ myeloid cells in mice that received B10.BR/Jdrif ATBM cells. The lymphocytic reconstitution observed in the spleen of mice receiving grafts from B10.BR/Jrep mice was similar to other reports using B10.BR donors in a BMT model (60) . Interestingly, mice receiving either CD4 ϩ or unseparated T cells along with B10.BR/Jdrif ATBM cells, although exhibiting similar lymphocytic reconstitution at day 25 post-BMT, demonstrated an increased life span as compared with mice receiving ATBM cells alone. The addition of mature T cells at time of transplant might temporarily assist peripheral reconstitution (61) and help protect against opportunistic infections, leading to delayed mortality. Studies have shown that delays in hematopoietic reconstitution in patients following BMT leads to high rates of mortality due to opportunistic infections (60) .
Alternatively, the inability of B10.BR/Jdrif ATBM cells to provide long-term survival of B10.BR/Jrep or B10.BR/Jdrif recipients may suggest that there is a failure of sustainable hematopoietic reconstitution. This failure could be a consequence of abnormal development of the less differentiated graft population (Lin Ϫ ), as opposed to effects by more mature lineage progenitor cells. Note that CBA recipients of B10.BR/Jdrif ATBM cells did not exhibit a significant drop-off of survival between 20 and 40 days post-BMT (Fig. 2) ; however, the recipients were conditioned with 8.5 Gy irradiation, compared with 11 Gy (split dose) for the B10.BR/ Jrep and B10.BR/Jdrif recipients (Fig. 5) . The lower irradiation exposure in the CBA recipient experiments may have allowed for survival of enough host stem cells to prevent hematopoietic failure (e.g., mice sampled for splenocyte Ly9.1 expression at 52 days post-BMT exhibited 70% donor chimerism).
Using a hematopoietic gene expression microarray analysis, we looked for differences in gene expression between Lin Ϫ bone marrow cells from either B10.BR/Jdrif or B10.BR/Jrep mice. The results indicated general B10.BR/Jdrif transcriptional up-regulation in the arrayed hematopoietic genes. Twenty-five arrayed genes were overexpressed in B10.BR/Jdrif mice compared with B10.BR/ Jrep mice, and two genes were underexpressed. Interestingly, several of the B10.BR/Jdrif overexpressed genes have been reported to affect hematopoietic stem cell (HSC) survival, differentiation, and reconstitution potential. The dysregulation of Rho family member Cdc42 (62) and of Vav1 (63), a guanine nucleotide exchange factor, have been shown to lead to increased HSC apoptosis. B10.BR/Jdrif Lin Ϫ cells also overexpressed Ctnnb1 in comparison to B10.BR/Jrep cells. Constitutive activation of this Wnt signaling mediator in HSC has been shown to cause defects in hematopoietic differentiation and reconstitution potential (64, 65) . Furthermore, Flt3 is a receptor tyrosine kinase that is normally expressed on hematopoietic stem/progenitor cells, plays a role in survival, proliferation, and differentiation (66) , and is overexpressed on most human B lineage and acute myeloid leukemias (67) . Interestingly, knockout mice deficient in Flt3 expression exhibit reduced numbers of myeloid progenitor cells (68) . Thus, overexpression of Flt3 may be at least partially responsible for the observed higher constitutive presence of NK and myeloid cells in normal B10.BR/Jdrif mice and in irradiated recipients of their bone marrow cells. While the mechanisms behind the variant B10.BR/ Jdrif transcriptional profile have not yet been determined, these results provide some direction for investigation into the nature of the potential B10.BR/Jdrif bone marrow cell defect. Whatever its cause, it seemingly is manifest only in the context of reconstitution; the hematopoietic system in normal B10.BR/Jdrif mice, while altered, obviously confers viability.
The precise genetic drift between the B10.BR/Jrep and B10.BR/ Jdrif strains remains to be identified. It is possible that variations in multiple genes separately led to at least one new miHA arising between the strains and to the transcriptional differences observed in the Lin Ϫ cells. On the other hand, pleiotropy could be involved. There were several transcription-associated genes (Ctnnb1, Cbfb, Hdac5, Hmgb3) differentially expressed between the B10.BR strains. Theoretically, these genes could regulate the expression of proteins related to HSC reconstitution and/or proteins with immunogenic potential.
Unfortunately, genetic drift is an unavoidable consequence of working with inbred mouse strains. However, it can also lead to the discovery of novel mutations that can be translated to human disease. In this case, we have uncovered altered alloreactivity and defects in hematopoietic reconstitution in the B10.BR3 CBA model of allogeneic BMT caused by genetic drift of the B10.BR strain. The discovery that the miHA disparity created by the drift leads to the development of CD4 ϩ T cell-mediated GVHD highlights the importance of miHA in GVHD pathology. Additionally, miHA are potential targets for anti-tumor responses. T cell alloreactivity aimed at miHA expressed only in the hematopoietic compartment have the potential to eliminate residual leukemic cells, while avoiding GVHD. Given the role that miHA play in GVHD and GVL responses, it is important to further identify and characterize the immune response elicited by these polymorphic Ags for the continued success of allogeneic BMT as a treatment option for hematological malignancies as well as immunotherapy for other forms of disease.
